Achala Pharmaceuticals Pvt Ltd
About Achala Pharmaceuticals Pvt Ltd
Data last updated:
Achala Pharmaceuticals Pvt Ltd is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the bakery and confectionery products segment of the food and beverages sector. It was incorporated on 15 February 1979 and has been in existence for over 47 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1979PTC021011. Its GSTIN is 27AAJCA1587E1ZN (Maharashtra).
The company has an authorised share capital of ₹95 Lakh and a paid-up capital of ₹70.93 Lakh. It is led by directors Radha Arvind Kunder and Arvind Chanda Kunder.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R 365 T C Area Rabale Thane Belapur Road, Navi Mumbai, Maharashtra, India – 400701.
As per the financials filed for FY 2024, the company reported a revenue of ₹36.64 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹6.95 Lakh (net margin 19%) and EBITDA of ₹8.39 Lakh (EBITDA margin 22.9%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Achala Pharmaceuticals Pvt Ltd's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressR 365 T C Area Rabale Thane Belapur Road, Navi Mumbai, Maharashtra, India – 400701
- IndustryFood and Beverages, Bakery & Confectionery Products
To see the full contact details of Achala Pharmaceuticals Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Achala Pharmaceuticals is manufacturing. In detail, this covers food, beverages and tobacco products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C1 | Food, beverages and tobacco products |
To see the full business activity and turnover split of Achala Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Achala Pharmaceuticals Pvt Ltd
FY 2025 filings availableAchala Pharmaceuticals Pvt Ltd reported revenue of ₹36.64 Lakh (down 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 3% fall in the latest year. EBITDA rose 224% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.39 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.9% | ||||
| Net Profit Margin | 19% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Achala Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Achala Pharmaceuticals Pvt Ltd
Achala Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Radha Arvind Kunder | Director | 15 Feb 1979 | 47 Years 8 Months | Current |
| Arvind Chanda Kunder | Director | 15 Feb 1979 | 47 Years 8 Months | Current |
Auditor
Achala Pharmaceuticals Pvt Ltd is audited by GODSE & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GODSE & ASSOCIATES | FY 2021 | 142480W |
Shareholding
The shareholding of Achala Pharmaceuticals Pvt Ltd is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Achala Pharmaceuticals Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Achala Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Achala Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Achala Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCA1587E1ZN | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Achala Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Achala Pharmaceuticals Pvt Ltd has 2 board changes on record since 1979: 2 appointments. The latest: Arvind Chanda Kunder was appointed as Director on 15 Feb 1979.
Frequently asked questions
Achala Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in bakery and confectionery products, within the food and beverages industry. It was incorporated on 15 February 1979 (47+ years old) and is registered under CIN U99999MH1979PTC021011.
Achala Pharmaceuticals has 2 current directors:
- Radha Arvind Kunder - Director
- Arvind Chanda Kunder - Director
The latest financial statements of Achala Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Achala Pharmaceuticals is 27AAJCA1587E1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Achala Pharmaceuticals is U99999MH1979PTC021011. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Achala Pharmaceuticals was incorporated on 15 February 1979, making it 47+ years old. It is registered with the Registrar of Companies, Mumbai.
Arvind Chanda Kunder was appointed as Director on 15 Feb 1979. Radha Arvind Kunder was appointed as Director on 15 Feb 1979.
The registered office of Achala Pharmaceuticals is at R 365 T C Area Rabale Thane Belapur Road, Navi Mumbai, Maharashtra, India – 400701.
Achala Pharmaceuticals operates in the food and beverages industry, in the bakery and confectionery products segment.
The compliance status of Achala Pharmaceuticals is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.